Technology News and Research

RSS

St. Mary Medical Center offers Frameless Stereotactic Radiosurgery treatment to fight cancer

For patients diagnosed with a brain tumor, St. Mary Medical Center is among the first in the region to offer Frameless Stereotactic Radiosurgery (SRS) as a breakthrough treatment to fight cancer. Frameless Stereotactic Radiosurgery is a one-time application of a large-dose radiation precisely targeting a tumor.

1 Oct 2009

UCF research team develops miniature diagnostic tool kit for dementia

With the risk of developing dementia growing at an alarming pace, a University of Central Florida research team is working with the Boston University School of Medicine to develop a miniature diagnostic toolkit in the hopes of stimulating earlier detection and treatment.

1 Oct 2009

Stanford Hospital invests $3 million in technology for safe patient handling

Swaddled in a cushy green hammock, the patient began her ascent off the bed. While one nurse regulated the speed of the lifting device, two of his colleagues guided the patient toward a bedside chair. Within seconds, she was securely lowered onto a cushion, and ready to begin rehabilitation exercises.

1 Oct 2009

Leading healthcare organizations choose DeviceAnywhere Test Center

As the Senate Finance Committee writes incentive bonuses for IT into the new “America’s Healthy Future Act” reform bill, there already exists a fast-growing roster of vendors and healthcare organizations delivering mobile applications that make health management more efficient, accessible, and cost-effective for the shared benefit of physicians, healthcare providers and consumers alike.

1 Oct 2009

Baxa launches new pricing model for IntelliFlowRx and Intellifill I.V. without capital investment

Baxa Corporation announces the launch of a new program for sourcing its IntelliFill i.v. Automation and IntelliFlowRx Pharmacy Workflow Manager products. The Baxa IntelliSource(TM) program offers health-system pharmacies access to the automation and software they need to ensure that each dose dispensed is safe and accurate - without making capital investments, paying one-time setup fees or signing capital leases.

1 Oct 2009

New medical breakthrough by Bioheart for treatment of patients with heart disorders

Bioheart, Inc. offers yet another medical breakthrough with the next-level stem cell treatment for cardiac patients. The stem cells aid in limiting damage due to a cardiac event and promote angiogenesis or formation of new blood vessels.

1 Oct 2009

Jindal to GOP: Time to say "here's what we're for"

In interviews Tuesday, Louisiana Gov. Bobby Jindal said Republicans need to lay out their own plans for health reform, rather than just rejecting Democratic proposals..

1 Oct 2009

Incept BioSystems commences human clinical trial of its SMART Embryo Culture System

Incept BioSystems, Inc., a privately-held biomedical device company using patented microfluidic technology developed at the University of Michigan, announced today that it has initiated the first U.S. human clinical trial of its proprietary SMART Embryo Culture System. The microscale SMART technology platform is designed to improve the in vitro manipulation, performance, and viability of embryos for the treatment of patients undergoing in vitro fertilization (IVF).

1 Oct 2009

Allscripts chosen as West Penn Allegheny's clinical IT solutions provider

Allscripts announced today a strategic agreement with West Penn Allegheny Health System (WPAHS) naming Allscripts as West Penn Allegheny's preferred provider of clinical IT solutions across its network of hospitals and owned physician practices.

1 Oct 2009

National E-Health Network remains industry challenge

As doctors and hospitals begin to transition to electronic medical records, one industry obstacle remains: ensuring that patients' records can smoothly follow them from one provider to another, the Associated Press reports. Though new stimulus funding for electronic records requires records to be "interoperable," or shareable, "the debate over interoperability among health care providers, which has been going on for years, could take well beyond the 2014 timeframe to be solved, industry experts say."

1 Oct 2009

Jagiellonian University to develop modern reagents for serological tests

Every year, 2 million patients in Poland are treated with blood and blood products. But only blood compatible with the recipient's blood type can be safely transfused.

1 Oct 2009

CDC Software expands operations in China, adds seven resellers

CDC Software Corporation, a global provider of enterprise software applications and services, today announced it has added seven resellers to its Global Partner Program as part of its previously announced expansion plans to position China as the second largest market, in terms of revenue, for the company in the next few years.

1 Oct 2009

Parabon Nanolabs receives SBIR grant to design DNA biometric devices

Parabon NanoLabs (PNL), a leading designer and manufacturer of breakthrough, nano-enabled products, announced today its award of a Department of Homeland Security (DHS) Small Business Innovative Research (SBIR) grant.

1 Oct 2009

Latest optical and laser technology in medicine displayed at FiO meeting

From scopes that help premature babies breathe to techniques for imaging live neurons and beating hearts as they develop, the latest optical and laser technology being deployed in medicine and the biosciences will be on display at the Optical Society's (OSA) Annual Meeting, Frontiers in Optics (FiO), which takes place Oct. 11-15 at the Fairmont San Jose Hotel and the Sainte Claire Hotel in San Jose, Calif.

1 Oct 2009

Can-Fite BioPharma commences preparatory work for a Phase III trial with CF101 to treat Psoriasis

Can-Fite BioPharma, a biotechnology company traded on the Tel Aviv Stock Exchange, an Israeli Biopharmaceutical company, announced today the initiation of preparatory work for a Phase III trial with CF101 in Psoriasis. This is based on the successful conclusion of a Phase II dose-response clinical study with CF101 to treat patients with moderate to severe Psoriasis; the study successfully met its primary objective of efficacy and safety

1 Oct 2009

IDC to supply DR systems for Indian hospitals

IDC (Imaging Dynamics Company Ltd.) (TSX: IDL), announced it was awarded three separate contracts in June 2009 with hospitals in India to supply its high end X-Series 1590 digital radiography (DR) systems and Magellan software following an extensive process in which the IDC CCD-based DR technology was determined to provide the best combination of value and clinical performance.

1 Oct 2009

U.S. patent for Idaho Technology’s high resolution nucleic acid melting techniques

Idaho Technology’s patent portfolio continues to grow as the U.S. Patent and Trademark Office granted the company U.S. Patent No. 7,582,429 relating to methods of performing genetic analysis in the presence of a double-stranded nucleic acid binding dye.

30 Sep 2009

TheraDoc's patient safety surveillance system helps hospitals manage their H1N1 responses effectively

As the battle against the H1N1 influenza outbreak continues, hospitals are on the front lines, charged with identifying, treating, monitoring, and reporting flu cases—as well as preventing their spread to other patients and hospital personnel. To facilitate this arduous task, a growing number of U.S. hospitals are using a patient safety surveillance system developed by TheraDoc that helps them more effectively coordinate their responses to this serious public health threat.

30 Sep 2009

Aphios awarded NIH grant to develop pathogen inactivation technology for blood products

Aphios Corporation today announced that it has been awarded a RC-1 Challenge grant (No. 1RC1HL102822-01) from the National Heart, Lung, and Blood Institute (NHLBI), National Institute of Health’s (NIH) American Recovery and Reinvestment Act (ARRA) funds to develop a generally-applicable pathogen inactivation technology for blood products.

30 Sep 2009

Inspirion Delivery Technologies completes Pre-IND meeting with the FDA

Inspirion Delivery Technologies, LLC ("IDT") announced today that last week the Company completed a pre-investigational new drug (Pre-IND) meeting with the U.S. Food and Drug Administration (FDA) to determine the clinical and regulatory pathway to advance its abuse deterrent, extended release formulation of oxycodone.

30 Sep 2009

Technology News and Research

St. Mary Medical Center offers Frameless Stereotactic Radiosurgery treatment to fight cancer

UCF research team develops miniature diagnostic tool kit for dementia

Stanford Hospital invests $3 million in technology for safe patient handling

Leading healthcare organizations choose DeviceAnywhere Test Center

Baxa launches new pricing model for IntelliFlowRx and Intellifill I.V. without capital investment

New medical breakthrough by Bioheart for treatment of patients with heart disorders

Jindal to GOP: Time to say "here's what we're for"

Incept BioSystems commences human clinical trial of its SMART Embryo Culture System

Allscripts chosen as West Penn Allegheny's clinical IT solutions provider

National E-Health Network remains industry challenge

Jagiellonian University to develop modern reagents for serological tests

CDC Software expands operations in China, adds seven resellers

Parabon Nanolabs receives SBIR grant to design DNA biometric devices

Latest optical and laser technology in medicine displayed at FiO meeting

Can-Fite BioPharma commences preparatory work for a Phase III trial with CF101 to treat Psoriasis

IDC to supply DR systems for Indian hospitals

U.S. patent for Idaho Technology’s high resolution nucleic acid melting techniques

TheraDoc's patient safety surveillance system helps hospitals manage their H1N1 responses effectively

Aphios awarded NIH grant to develop pathogen inactivation technology for blood products

Inspirion Delivery Technologies completes Pre-IND meeting with the FDA

Industry Focus eBook - Cell biology (5th edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News